| Literature DB >> 19619288 |
Amy C Spriggs1, Felix D Dakora.
Abstract
BACKGROUND: Symbiotic N2 fixation in legumes is constrained by many factors, including the paucity of suitable soil rhizobia To maximise growth of legume species therefore often requires the application of effective rhizobia as inoculants. But where native strains out-compete introduced rhizobia for nodule formation, it is important that the competitiveness of selected strains is tested in the field and glasshouse prior to their recommendation as commercial inoculants. However the methodology for strain identification inside nodules has often proved difficult and thus limited this field of research. In this study, the suitability of the antibiotic resistance technique (both intrinsic low-resistance fingerprinting and high-resistance marking) and the serological indirect ELISA method were assessed for their ability to detect selected Cyclopia rhizobia under glasshouse and field conditions. The four rhizobial strains that were used, namely PPRICI3, UCT40a, UCT44b and UCT61a, were isolated from wild Cyclopia species growing in the Western Cape fynbos of South Africa.Entities:
Mesh:
Year: 2009 PMID: 19619288 PMCID: PMC2724382 DOI: 10.1186/1471-2180-9-142
Source DB: PubMed Journal: BMC Microbiol ISSN: 1471-2180 Impact factor: 3.605
Levels of antibiotics used to develop resistant mutant strains of Cyclopia.
| Antibiotic | Concentration of antibiotics used (μg.ml-1) | |||
|---|---|---|---|---|
| Streptomycin | 1 | 1 | 10 | 5 |
| Spectinomycin | 10 | 5 | 80 | 80 |
Figure 1Intrinsic natural resistance of . Values are mean colony-forming units (CFU) per plate (n = 3 and error bars represent standard errors).
Nitrogen-fixing ability of marked rhizobial strains.
| Treatment | Total dry weight (mg) | Nodule biomass (mg) | Nodule number |
|---|---|---|---|
| Uninoculated | 0.06 ± 0.04 a | 0.00 ± 0.00 a | 0.0 ± 0.0 a |
| Inoculated | 0.72 ± 0.01 b | 33.33 ± 0.07 b | 19.6 ± 0.1 b |
| PPRICI3 Parent | 0.87 ± 0.13 | 18.60 ± 0.64 | 14.8 ± 0.5 |
| PPRICI3 | 0.70 ± 0.14 | 23.60 ± 0.78 | 13.2 ± 0.7 |
| PPRICI3 | 0.68 ± 0.10 | 15.40 ± 0.48 | 11.2 ± 0.5 |
| PPRICI3 | 1.26 ± 0.13 | 18.00 ± 0.62 | 12.6 ± 0.5 |
| UCT40a Parent | 2.26 ± 0.19 a | 75.76 ± 1.36 a | 20.0 ± 0.7 a |
| UCT40a | 1.83 ± 0.23 a | 74.70 ± 1.38 a | 24.3 ± 0.7 a |
| UCT40a | 2.13 ± 0.20 a | 81.94 ± 1.20 a | 31.6 ± 0.7 a |
| UCT40a | 0.12 ± 0.06 b | 0.00 ± 0.00 b | 0.0 ± 0.0 b |
| UCT44b Parent | 0.37 ± 0.13 | 31.25 ± 0.43 | 18.0 ± 0.4 |
| UCT44b | 0.90 ± 0.12 | 56.00 ± 0.81 | 33.4 ± 0.8 |
| UCT44b | 0.51 ± 0.09 | 23.20 ± 0.47 | 18.4 ± 0.5 |
| UCT44b | 0.66 ± 0.12 | 25.60 ± 0.60 | 18.2 ± 0.6 |
| UCT61a Parent | 0.84 ± 0.12 | 39.82 ± 0.93 | 25.4 ± 0.7 |
| UCT61a | 0.54 ± 0.09 | 22.64 ± 0.44 | 16.0 ± 0.5 |
| UCT61a | 0.61 ± 0.10 | 34.02 ± 0.73 | 21.6 ± 0.5 |
| UCT61a | 1.07 ± 0.14 | 48.10 ± 1.04 | 32.0 ± 0.8 |
Values are mean ± SE (n = 5) and different letters within a column indicate significant differences. ** Denotes a significant effect at P < 0.01, * = P < 0.05 and ns = no significant effect.
Competitiveness of antibiotically-marked strains compared to their unmarked parents.
| Treatment | Number of isolates tested | Number able to grow on YMA + antibiotics | % nodule occupancy by marked strain | Competitive ability of marked strain |
|---|---|---|---|---|
| UCT40a + UCT40a | 40 | 30 | 75.0 | I |
| UCT40a + UCT40a | 28 | 14 | 50.0 | U |
| UCT44b + UCT44b | 18 | 4 | 22.2 | R |
| UCT44b + UCT44b | 38 | 12 | 31.6 | R |
| UCT44b + UCT44b | 26 | 10 | 38.5 | U |
| UCT61a + UCT61a | 50 | 0 | 0.0 | R |
| UCT61a + UCT61a | 52 | 0 | 0.0 | R |
| UCT61a + UCT61a | 60 | 0 | 0.0 | R |
| PPRICI3 + PPRICI3 | 35 | 21 | 60.0 | U |
| PPRICI3 + PPRICI3 | 31 | 19 | 61.2 | U |
| PPRICI3 + PPRICI3 | 31 | 10 | 32.3 | U |
* Denotes significant deviation from the expected frequency of 50% nodule occupancy using a χ2 test on pooled data, P < 0.05. Symbols indicate I = increased, U = unchanged and R = reduced competitive ability of the marked strain compared to its unmarked parent.
Retention of the antibiotic resistance marker after plant passage.
| Marked Strain | Number of isolates tested | Number able to grow on YMA + antibiotics | % retention of antibiotic resistance |
|---|---|---|---|
| UCT40a | 25 | 23 | 92 |
| UCT40a | 25 | 25 | 100 |
| UCT44b | 20 | 20 | 100 |
| UCT44b | 21 | 17 | 81 |
| UCT44b | 19 | 16 | 84 |
| UCT61a | 15 | 0 | 0 |
| UCT61a | 14 | 0 | 0 |
| UCT61a | 13 | 13 | 100 |
| PPRICI3 | 19 | 19 | 100 |
| PPRICI3 | 19 | 19 | 100 |
| PPRICI3 | 20 | 20 | 100 |
Figure 2Cross-reaction tests of indirect ELISAs involving primary antibodies assayed against 4 test antigens, with plant tissue and PBS as controls. Nine antigens prepared for each test strain were assayed in duplicates. Error bars representing standard errors ranged from 0.001 – 0.006 OD405.
Cross-reaction tests of indirect ELISAs involving primary antibodies assayed against random antigens extracted from 3 different field soils.
| Antigen (field soil site) | 1° antibody | |||
|---|---|---|---|---|
| Waboomskraal | 60 | 0 | 0 | 0 |
| Rein's Farms | 90 | 0 | 0 | 0 |
| Kanetberg | 55 | 0 | 3 | 0 |
Data are % antigens tested positive (≥ 1.0 OD405), n = 30, assayed in duplicates.